Ajanta Pharma gets USFDA nod for Fluphenazine Hydrochloride tablet

Ajanta Pharma gets USFDA nod for Fluphenazine Hydrochloride tablet

The drug is used to treat psychotic disorders such as schizophrenia

FPJ Web DeskUpdated: Tuesday, January 10, 2023, 04:01 PM IST
article-image
Ajanta Pharma gets USFDA nod for Fluphenazine Hydrochloride tablet | Image: Ajanta Pharma (Representative)

Ajanta Pharma Ltd has received an approval from the US Food and Drug Administration (USFDA) for Fluphenazine Hydrochloride tablet, as per an exchange filing.

The dosage is in 1 mg, 2.5 mg, 5 mg and 10 mg strengths, according to an update on the drug regulator's website.

The drug is used to treat psychotic disorders such as schizophrenia.

RECENT STORIES

58 Child Labourers Rescued From Som Distillery In MP's Raisen; Were Taken To Work Via School Bus...

58 Child Labourers Rescued From Som Distillery In MP's Raisen; Were Taken To Work Via School Bus...

'Bad Food, Worn Out, Dirty Seat Covers': Air India Business Class Passenger Shares Account Of His...

'Bad Food, Worn Out, Dirty Seat Covers': Air India Business Class Passenger Shares Account Of His...

Income Tax Relief For Those In Lowest Slab May Need To Be Considered In Budget: CII

Income Tax Relief For Those In Lowest Slab May Need To Be Considered In Budget: CII

Microsoft Presses Pause On Controversial AI-Powered 'Recall' Feature

Microsoft Presses Pause On Controversial AI-Powered 'Recall' Feature

Indian Telecom Companies Start Caller ID Display Trials To Mitigate Spam Menace: Report

Indian Telecom Companies Start Caller ID Display Trials To Mitigate Spam Menace: Report